In summary, this study found that UTP14A acts as a promoter in ESCC metastasis and proliferation, which may be achieved through the PERK/eIF2a signalling pathway and its induced expression. This evidence concerns the gene EIF2AK3 and esophageal squamous cell carcinoma.